OMT-28

OMT-28 is a synthetic analog of omega-3 epoxyeicosatrienoic acids developed for atrial fibrillation.[1][2]

## References

1. ↑ Berlin, Sarah; Goette, Andreas; Summo, Luciana; Lossie, Janine; Gebauer, Alexander; Al-Saady, Naab; Calo, Leonardo; Naccarelli, Gerald et al. (August 2020). "Assessment of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids, in patients with persistent atrial fibrillation: Rationale and design of the PROMISE-AF phase II study". IJC Heart & Vasculature 29: 100573. doi:10.1016/j.ijcha.2020.100573. PMID 32685659.
2. ↑ Dan, Gheorghe-Andrei (6 August 2020). "Non-traditional antiarrhythmic drugs as upstream and downstream dam for atrial fibrillation burden". International Journal of Cardiology. Heart & Vasculature 29: 100610. doi:10.1016/j.ijcha.2020.100610. ISSN 2352-9067. PMID 32885033.

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/OMT-28. Read more

|

Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:OMT-28&oldid=2676696"